Analytical Method Development and Validation
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract requires the development and validation of bioanalytical methods, including LC-MS/MS and ELISA, to accurately quantify drugs and their metabolites in biological matrices for use in pharmacokinetic and toxicology studies. These methods must meet industry standards for accuracy, precision, specificity, sensitivity, and reproducibility to ensure reliable data generation under regulatory expectations. The work is scoped to support preclinical and clinical research initiatives aimed at understanding drug behavior and safety profiles within biological systems. The contract is classified as a subcontract under NAICS code 541380, issued by the National Institutes of Health NIDA within the Department of Health and Human Services, with performance expected in Bethesda. The solicitation was posted on August 3, 2026, and responses are due by August 18, 2026. There is no set-aside designation specified, and the place of performance is restricted to Bethesda, indicating that all analytical work, data reporting, and validation documentation must be conducted on-site. While no point of contact is listed, applicants must ensure compliance with the technical scope, timelines, and quality benchmarks required to support NIH-funded research programs.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida
Same awarding agency
